Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation

20260 citationsJournal Articlehybrid Open Access

Authors

Jeremy A. Bartlett · Pfizer (United States)

Natalie Culver · Pfizer (United States)

M. M. M. Santangelo · Pfizer (United States)

Andrew Prpich · Pfizer (United States)

Erica Long · Pfizer (United States)

Kazuko Sagawa · Pfizer (United States)

Ravi Shanker ·

Abstract

gov trial registration number (date of registration): NCT00939770 (15 Jul 2009), NCT01606878 (28 May 2012), NCT02006277 (10 Dec 2013), NCT03137134 (02 May 2017), NCT03978143 (06 Jun 2019), NCT04856293 (23 Apr 2021, retrospectively registered).

Topics & Keywords

Pharmaceutical studies and practices Lung Cancer Treatments and Mutations Chemotherapy-related skin toxicity

Publication Details

Published in: Pharmaceutical Medicine

DOI: 10.1007/s40290-026-00604-2

Field-Weighted Citation Impact: 0.00

Command Palette

Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation

Authors

Abstract

Topics & Keywords

Publication Details